Selected article for: "acute ards respiratory distress syndrome and lymphocyte count lymphocyte ratio"
Author: Ponti, Giovanni; Maccaferri, Monia; Ruini, Cristel; Tomasi, Aldo; Ozben, Tomris
Title: Biomarkers associated with COVID-19 disease progression
  • Cord-id: 3l2t9w9l
  • Document date: 2020_6_5
    • ID: 3l2t9w9l
    Snippet: The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is centered on the unpredictable clinical course of the disease that can rapidly develop, causing severe and deadly complications. The identification of effective laboratory biomarkers able to classify patients based on their risk is imperative in being able to guarantee prompt treatment. The analysis of recently publi
    Document: The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is centered on the unpredictable clinical course of the disease that can rapidly develop, causing severe and deadly complications. The identification of effective laboratory biomarkers able to classify patients based on their risk is imperative in being able to guarantee prompt treatment. The analysis of recently published studies highlights the role of systemic vasculitis and cytokine mediated coagulation disorders as the principal actors of multi organ failure in patients with severe COVID-19 complications. The following biomarkers have been identified: hematological (lymphocyte count, neutrophil count, neutrophil–lymphocyte ratio (NLR)), inflammatory (C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT)), immunological (interleukin (IL)-6 and biochemical (D-dimer, troponin, creatine kinase (CK), aspartate aminotransferase (AST)), especially those related to coagulation cascades in disseminated intravascular coagulation (DIC) and acute respiratory distress syndrome (ARDS). New laboratory biomarkers could be identified through the accurate analysis of multicentric case series; in particular, homocysteine and angiotensin II could play a significant role.

    Search related documents:
    Co phrase search for related documents
    • abnormal coagulation and liver function: 1, 2, 3, 4
    • abnormal coagulation and liver injury: 1, 2, 3
    • abnormal coagulation and logistic analysis: 1, 2
    • abnormal coagulation and low density: 1
    • abnormally high and liver function: 1
    • abnormally high and liver injury: 1
    • abnormally high and low density: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and logistic analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and low density: 1, 2, 3, 4, 5, 6, 7
    • acute lung injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute lung injury and low density: 1, 2, 3
    • admission patient and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • admission patient and liver injury: 1, 2, 3, 4, 5
    • admission patient and logistic analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • admission patient and low density: 1
    • liver abnormality and logistic analysis: 1, 2, 3
    • liver abnormality and low density: 1